Concepedia

Samuel Peña‐Díaz

SP

15

Publications

782

Citations

13

H-Index

2017

Active since

Affiliations

Universitat Autònoma de Barcelona(Current)

Institució Catalana de Recerca i Estudis Avançats

Universidad de Zaragoza

Institute for Research in Biomedicine

Universitat de Vic - Universitat Central de Catalunya

Samuel Peña‐Díaz is an author at Universitat Autònoma de Barcelona specializing in medicine, molecular biology, and natural sciences.

ORCID

Top concepts

Publications per year

2017–2024

15

Publications

15

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

Jordi Pujols, Samuel Peña‐Díaz, Diana F. Lázaro et al. · Proceedings of the National Academy of Sciences · 2018 · 224 citations · Full text

DisProt in 2022: improved quality and accessibility of protein intrinsic disorder annotation

Federica Quaglia, Bálint Mészáros, Edoardo Salladini et al. · Nucleic Acids Research · 2021 · 184 citations · Full text

, , +21

High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors

Jordi Pujols, Samuel Peña‐Díaz, María Conde-Giménez et al. · International Journal of Molecular Sciences · 2017 · 71 citations · Full text

, , +21

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

Jaime Santos, Pablo Gracia, Susanna Navarro et al. · Nature Communications · 2021 · 68 citations · Full text

ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization

Samuel Peña‐Díaz, Jordi Pujols, María Conde-Giménez et al. · Frontiers in Molecular Neuroscience · 2019 · 36 citations · Full text

Rows per page

1–5 of 15